Global Antimony-124 Market Growth 2025-2031

The global Antimony-124 market size is predicted to grow from US$ 6.6 million in 2025 to US$ 10.3 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

Antimony-124 is a radioactive isotope of the element antimony. It is radioactive and can emit gamma rays. It is mainly used as a neutron source. When used together with beryllium, it can trigger the photodisintegration of beryllium and release neutrons. In addition, it can also be used to test the synthesis and volatility of potassium antimony tartrate in blood, as a tracer atom in experiments.

United States market for Antimony-124 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Antimony-124 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Antimony-124 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Antimony-124 players cover POLATOM, Ningbo Inno Pharmchem Co., Ltd., MuseChem, THE BioTek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Antimony-124 Industry Forecast” looks at past sales and reviews total world Antimony-124 sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimony-124 sales for 2025 through 2031. With Antimony-124 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimony-124 industry.

This Insight Report provides a comprehensive analysis of the global Antimony-124 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimony-124 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antimony-124 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimony-124 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimony-124.

This report presents a comprehensive overview, market shares, and growth opportunities of Antimony-124 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Radionuclidic Purity:>99%
Radionuclidic Purity:≤99%

Segmentation by Application:
Neutron Source
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
POLATOM
Ningbo Inno Pharmchem Co., Ltd.
MuseChem
THE BioTek

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antimony-124 market?

What factors are driving Antimony-124 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antimony-124 market opportunities vary by end market size?

How does Antimony-124 break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.